CStone appoints three distinguished oncology leaders Drs. Paul A. Bunn, Jr., Elizabeth M. Jaffee and Richard S. Finn to its Scientific Advisory Board |
March 25, 2019 | March 2019 Bond Updates |
SHANGHAI, March 25, 2019 /PRNewswire/ -- CStone Pharmaceuticals ("CStone"; HKEX: 2616) is pleased to announce the appointment of three internationally renowned oncologists Paul A. Bunn, Jr., MD, Elizabeth M. Jaffee, MD, and Richard S. Finn, MD, as the company's Scientific Advisory Board... |
View more at: https://www.prnewswire.com:443/news-releases/cstone-appoints-three-distinguished-oncology-leaders-drs-paul-a-bunn-jr-elizabeth-m-jaffee-and-richard-s-finn-to-its-scientific-advisory-board-300817542.html |
Related News |
|